Russia’s Medtech Revolution
Russia’s health care authorities are building a modern system to meet the needs of a growing population and better regulation of entry into the $6 billion medical device market is an important element of this wider aim. Alexandra Tretiakova, executive director of Russia’s International Medical Device Manufacturers Association, weighs in on how the complex new set of rules will impact the medtech industry.
You may also be interested in...
Russian medtech industry expert Alexey Stepanov reports an uptick in regulatory activity nationally in the final trimester of 2016. The catalyst seems to be the impending launch of the system of harmonization of medical device regulation within the regional Eurasian Economic Union (EAEU).
The company cited lackluster efficacy in its decision to discontinue development of V590 and V591. It will instead develop two drugs to treat COVID-19.
The regulatory tools are for use in medical device development.